Role of R5 phenotypic variation in mother-to-child transmission of HIV-1 by unknown
BioMed CentralRetrovirology
ssOpen AcceOral presentation
Role of R5 phenotypic variation in mother-to-child transmission of 
HIV-1
Mariangela Cavarelli*1, Ingrid Karlsson2, Marisa Zanchetta3, 
Liselotte Antonsson4, Anna Plebani5, Carlo Giaquinto6, Eva Maria Fenyö2, 
Anita De Rossi3 and Gabriella Scarlatti1
Address: 1Viral Evolution and Transmission Unit, DIBIT, Fondazione Centro San Raffaele, Milan, 20132, Italy, 2Division of Medical Microbiology/
Virology, Department of Laboratory Medicine, Lund University, Lund, 223 62, Sweden, 3Department of Oncology and Surgical Sciences, Unit of 
Viral Oncology, AIDS Reference Center, University of Padova, IOV-IRCCS, Padova, 35022, Italy, 4Division of Cellular and Molecular 
Pharmacology, Department of Experimental Medical Science, Lund University, Lund, 223 62, Sweden, 5Department of Pediatrics, University of 
Milan, Clinica De Marchi, Milan, 20122, Italy and 6Department of Pediatrics, University of Padova, 35022, Italy
* Corresponding author    
Background
R5 viruses were shown to have an intrinsic phenotypic
variation, as demonstrated by their capacity to differen-
tially infect in vitro target cells expressing CCR5/CXCR4
chimeric receptors [1,2]. In this study we have explored
the hypothesis that the phenotypic variation of R5 viruses
of pregnant women could play a role in mother-to-child
transmission (MTCT) of HIV-1.
Materials and methods
Virus isolates obtained from 59 mothers (24 transmitting
and 35 non transmitting) and from 24 infected children
were tested for their ability to infect U87.CD4 cells
expressing the wild type chemokine receptors CCR5 or
CXCR4, or the six CCR5/CXCR4 chimeric receptors.
Results
Transmitting mothers (7 out of 24) carried more often
viruses able to use both CCR5 and CXCR4 coreceptors
than non transmitting mothers (3 out of 35) (p=ns). The
analysis of the chimeric receptor usage showed that 57.1%
of maternal R5 isolates displayed an R5narrow phenotype
(28 out of 49 R5 viruses), as they exclusively used wild
type CCR5 and none of the chimeric receptors and were
similarly distributed in transmitting and non transmitting
mothers. Multiple chimeric receptor using viruses
(R5broad) were more frequent in non-transmitting moth-
ers than in transmitting mothers (in 15 and 6, respec-
tively; p=ns), and utilized more frequently one specific
chimeric receptor (FC4b) (13/15 vs. 2/6, respectively;
p=0.056), but were independent from transmission event.
To understand if selective processes occur during trans-
mission, we compared the phenotype of the virus isolates
of 21 mother-child pairs. All ten mothers harbouring an
R5narrow virus had children who displayed the same viral
phenotype. Interestingly, the six mothers carrying
R5broad viruses transmitted in all but one case a virus
with an identical or similar broad chimeric receptor usage.
On the contrary, the five mothers with an R5X4 virus
transmitted the whole spectrum of virus phenotypes: two
R5narrow, two R5broad and one R5X4.
Conclusions
Our results show that the presence of an R5broad virus
appears not to be prognostic of MTCT of HIV-1. The
majority of viruses replicating at a time point close to
infection are restrictive to the use of wild type CCR5, how-
ever, transmission of R5broad viruses is not limited.
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